AHL Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$2.87M Buy
19,643
+3,964
+25% +$565K 0.04% 622
2017
Q3
$2.13M Sell
15,679
-45,341
-74% -$5.73M 0.04% 653
2017
Q2
$7.64M Buy
61,020
+49,833
+445% +$5.96M 0.16% 190
2017
Q1
$1.33M Sell
11,187
-16,753
-60% -$2.01M 0.03% 721
2016
Q4
$3.22M Buy
27,940
+19,193
+219% +$2.14M 0.1% 378
2016
Q3
$914K Buy
+8,747
New +$913K 0.03% 628
2015
Q1
Sell
-33,828
Closed -$3M 800
2014
Q4
$3M Buy
33,828
+29,816
+743% +$2.53M 0.15% 238
2014
Q3
$321K Buy
+4,012
New +$302K 0.02% 582

Other funds holding CME

AHL Partners's CME Position: Q4 2017 in Review

AHL Partners increased its CME Group (CME) stake by 25% in Q4 2017, buying an estimated $565K and bringing the position to 19,643 shares worth $2.87M. The position accounts for 0.04% of the portfolio, ranked #622.

AHL Partners first reported a position in CME in Q3 2014 and has held it in 8 quarters since. The position peaked at $7.64M in Q2 2017. 855 funds tracked by Wall St. Rank hold CME as of Q4 2017.

  • AHL Partners held 19,643 shares of CME Group worth $2.87M as of Q4 2017.
  • AHL Partners bought 3,964 CME Group shares in Q4 2017, an estimated $565K.
  • CME Group made up 0.04% of AHL Partners's portfolio in Q4 2017, its #622 holding.
  • AHL Partners first reported a position in CME Group in Q3 2014 and has held it in 8 quarters since.
  • AHL Partners's CME Group position peaked at $7.64M in Q2 2017.
  • 855 funds tracked by Wall St. Rank held CME Group as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.